Talaris Therapeutics Inc. (TALS)
NASDAQ: TALS
· Real-Time Price · USD
2.72
-0.02 (-0.73%)
At close: Oct 19, 2023, 10:00 PM
Talaris Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 31.42M | 35.33M | 30.51M | 35.01M | 70.15M | 67.08M | 18.35M | 24.22M | 13.67M | 18.47M | 25.52M | 22.79M | 18.61M | 27.31M | 36.3M | 9.89M |
Short-Term Investments | 207.81M | 213.98M | 227.8M | 246.92M | 219.38M | 79.94M | 133.9M | 141.59M | 167.61M | 175.4M | 181.59M | 202.74M | 225.36M | 227.42M | 229.92M | 130.21M |
Long-Term Investments | 17.18M | 26M | 36.63M | 32.47M | 44.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 2.84M | 3.13M | 3.26M | 1.89M | 1.43M | 14K | 1.86M | 111K | 111K | 111K | 111K | 111K | 104K | 104K | 89K | 14K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 477K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.16M |
Other Current Assets | 9.87M | 8.84M | 10.54M | 11.86M | 8.59M | 4.02M | 3.96M | 3.05M | 4.33M | 4.26M | 4.92M | 2.89M | 2.54M | 3.49M | 4.25M | 2.7M |
Total Current Assets | 249.1M | 258.14M | 268.84M | 293.79M | 298.13M | 151.05M | 156.21M | 168.86M | 185.61M | 198.13M | 212.04M | 228.42M | 246.51M | 258.23M | 270.47M | 142.8M |
Property-Plant & Equipment | 174K | 229K | 267K | 307K | 355K | n/a | 1.05M | 3.64M | 7.99M | 8.31M | 8.77M | 8.72M | 4.8M | 2.99M | 2.25M | 2.08M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 20.19M | 29.35M | 40.16M | 34.66M | 46.66M | 14K | 2.91M | 3.75M | 8.1M | 8.42M | 8.88M | 8.83M | 4.91M | 3.1M | 2.34M | 2.1M |
Total Assets | 269.3M | 287.5M | 309M | 328.45M | 344.79M | 151.06M | 159.12M | 172.61M | 193.72M | 206.54M | 220.92M | 237.25M | 251.42M | 261.32M | 272.81M | 144.9M |
Account Payables | 3.17M | 2.23M | 3.58M | 2.05M | 2.39M | 136K | 2.93M | 3.38M | 3.89M | 2.13M | 2.08M | 3.48M | 2.56M | 1.18M | 1.26M | 769K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 6.35M | n/a | n/a | n/a | n/a | 3.1M | n/a | n/a | n/a | n/a |
Short-Term Debt | 145K | 196K | 227K | 226K | 224K | 634K | 601K | 751K | 910K | 905K | 835K | 740K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 9.95M | 7.43M | 8.68M | 7.06M | 3.75M | 7.33M | 6.6M | 6.04M | 6.67M | 6.13M | 4.42M | 3.84M | 5.43M | 3.8M | 3.4M | 2.81M |
Total Current Liabilities | 10.1M | 7.62M | 8.91M | 7.28M | 6.36M | 8.11M | 10.13M | 10.18M | 11.46M | 9.17M | 7.33M | 8.06M | 7.99M | 4.98M | 4.66M | 3.58M |
Long-Term Debt | n/a | n/a | 17K | 64K | 109K | n/a | 425K | 521K | 1.97M | 2.2M | 2.43M | 2.66M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 8K | 13K | 23K | 31K | 39K | 82K | 130K | 176K | 224K | 310K | 413K | 492K | 626K | 694K | 800K | 187.78M |
Total Long-Term Liabilities | 8K | 13K | 40K | 95K | 148K | 82K | 555K | 697K | 2.2M | 2.51M | 2.84M | 3.15M | 626K | 694K | 800K | 187.78M |
Total Liabilities | 10.1M | 7.63M | 8.95M | 7.38M | 6.51M | 8.19M | 10.69M | 10.88M | 13.66M | 11.68M | 10.17M | 11.22M | 8.61M | 5.68M | 5.46M | 191.37M |
Total Debt | 145K | 196K | 244K | 290K | 333K | 634K | 1.03M | 1.27M | 2.88M | 3.1M | 3.27M | 3.4M | n/a | n/a | n/a | n/a |
Common Stock | 3K | 3K | 3K | 3K | 3K | n/a | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 1K |
Retained Earnings | -181.32M | -158.23M | -135.26M | -113.03M | -92.85M | -208.99M | -201.98M | -187.24M | -164.74M | -146.21M | -127.2M | -109.11M | -90.85M | -76.61M | -63.66M | -52.31M |
Comprehensive Income | 121K | 227K | 296K | 821K | -452K | -115K | -214K | -299K | -721K | -1.22M | -1.14M | -926K | -78K | 29K | 34K | 9K |
Shareholders Equity | 259.19M | 279.86M | 300.05M | 321.07M | 338.28M | 142.87M | 148.43M | 161.73M | 180.06M | 194.87M | 210.74M | 226.03M | 242.81M | 255.65M | 267.35M | -46.47M |
Total Investments | 225M | 239.98M | 264.43M | 279.38M | 264.26M | 79.94M | 133.9M | 141.59M | 167.61M | 175.4M | 181.59M | 202.74M | 225.36M | 227.42M | 229.92M | 130.21M |